Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 236 clinical trials
HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-risk Patients With Breast Cancer (HYPART).

We at PGIMER have been practicing hypofractionated radiotherapy in breast cancer patients for the last 4 decades. Our standard doses have been 35Gy/15/3wks to the chest wall after mastectomy and 40Gy/16/3wks after breast conserving surgery (BCS).It is also a routine practice in the UK and in a few centers in …

trastuzumab
invasive carcinoma
adjuvant chemotherapy
hormone therapy
breast-conserving surgery
  • 0 views
  • 01 Jul, 2021
  • 1 location
Progesterone and Resting Energy Expenditure

This study evaluates the effect of micronized progesterone substitution in the luteal phase on resting energy expenditure in women during menopausal transition.

progesterone
body mass index
  • 0 views
  • 28 Jan, 2021
  • 1 location
Progesterone in Expectantly Managed Early-onset Preeclampsia

Preeclampsia is a disorder of widespread vascular endothelial malfunction and vasospasm that occurs after 20 weeks' gestation and can present as late as 4-6 weeks postpartum

progesterone
vasospasm
  • 5 views
  • 30 Apr, 2021
  • 1 location
Pessary Versus Cerclage With or Without Progesterone in Twins

This study compares the effectiveness of cervical pessary and cervical cerclage with or without vaginal progesterone for prevention of preterm birth in women with a twin pregnancy and a cervix

cervical cerclage
progesterone
  • 0 views
  • 25 Jan, 2021
  • 1 location
Luteal Support in Artificial Vitrified/Warmed Cycles With Low Progesterone

The study aims to evaluate the effect of an increased dose of vaginal progesterone supplementation on the incidence of ongoing pregnancy for patients with a suboptimal serum progesterone level

progesterone
body mass index
  • 0 views
  • 18 Jun, 2021
  • 1 location
Androgen Blockade and Progesterone Augmentation of Gonadotropin Secretion

generation) in PCOS. This is a randomized, placebo-controlled, double-blinded, crossover study. The investigators hypothesize that in estradiol-pretreated women with PCOS, acute progesterone augmentation of

  • 0 views
  • 28 Jan, 2021
  • 1 location
Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone

During childhood, the levels of certain hormones: gonadotropin-releasing hormone (GnRH), luteinizing hormone (LH), follicle-stimulating hormone (FSH), estrogen, and progesterone are very low

gonadorelin
gonadotropin
estradiol
testosterone level
follicle stimulating hormone
  • 61 views
  • 25 Jan, 2021
  • 1 location
Vaginal Progesterone for the Prolongation of Pregnancy After Arrested Pre-term Labor

Patients diagnosed with arrested pre-term labor following tocolytics at 24-34 gestational weeks will be randomly allocated to receive either vaginal micronized progesterone 400 mg/day or no

tocolytic agent
premature birth
tocolysis
progesterone
progesterone 400 mg
  • 0 views
  • 25 Jan, 2021
  • 2 locations
Omega 3 Plus Vaginal Progesterone on Birth Weight of Intrauterine Growth-restricted Fetuses

. Progesterone is a smooth muscle relaxant and has a vasodilator effect on the blood vessels. It causes endothelium- relaxation of human placental arteries and veins. This relaxation is

smooth muscle relaxant
perinatal morbidity
termination of pregnancy
antioxidants
fatty acids
  • 0 views
  • 25 Jan, 2021
  • 1 location
Onapristone and Anastrozole in Refractory Estrogen and Progesterone Positive Endometrial Cancer

(refractory). Progesterone and estrogen are hormones that can cause the growth of endometrial cancer cells. Onapristone blocks the use of progesterone by the tumor cells. Anastrozole is a drug that blocks the

metastasis
carcinosarcoma
carcinoma
adenocarcinoma
measurable disease
  • 0 views
  • 12 Jun, 2021
  • 2 locations